Advertisement

Cerebral Creatine Deficiency Syndromes: Clinical Aspects, Treatment and Pathophysiology

  • Sylvia Stockler
  • Peter W. Schutz
  • Gajja S. Salomons
Part of the Subcellular Biochemistry book series (SCBI, volume 46)

Abstract

Cerebral creatine deficiency syndromes (CCDSs) are a group of inborn errors of creatine metabolism comprising two autosomal recessive disorders that affect the biosynthesis of creatine – i.e. arginine:glycine amidinotransferase deficiency (AGAT; MIM 602360) and guanidinoacetate methyltransferase deficiency (GAMT; MIM 601240) – and an X-linked defect that affects the creatine transporter, SLC6A8 deficiency (SLC6A8; MIM 300036). The biochemical hallmarks of these disorders include cerebral creatine deficiency as detected in vivo by 1H magnetic resonance spectroscopy (MRS) of the brain, and specific disturbances in metabolites of creatine metabolism in body fluids. In urine and plasma, abnormal guanidinoacetic acid (GAA) levels are found in AGAT deficiency (reduced GAA) and in GAMT deficiency (increased GAA). In urine of males with SLC6A8 deficiency, an increased creatine/creatinine ratio is detected. The common clinical presentation in CCDS includes mental retardation, expressive speech and language delay, autistic like behaviour and epilepsy. Treatment of the creatine biosynthesis defects has yielded clinical improvement, while for creatine transporter deficiency, successful treatment strategies still need to be discovered. CCDSs may be responsible for a considerable fraction of children and adults affected with mental retardation of unknown etiology. Thus, screening for this group of disorders should be included in the differential diagnosis of this population. In this review, also the importance of CCDSs for the unravelling of the (patho)physiology of cerebral creatine metabolism is discussed

Keywords

Creatine Monohydrate Creatine Transporter Creatine Synthesis Guanidino Compound GAMT Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Almeida, L.S., Rosenberg, E.H., Verhoeven, N.M., Jakobs, C., and Salomons, G.S., 2006a, Are cerebral creatine deficiency syndromes on the radar screen? Future Neurol. 1: 637–649.CrossRefGoogle Scholar
  2. Almeida, L.S., Salomons, G.S., Hogenboom, F., Jakobs, C., and Schoffelmeer, A.N., 2006b, Exocytotic release of creatine in rat brain. Synapse 60: 118–123.CrossRefGoogle Scholar
  3. Almeida, L.S., Verhoeven, N.M., Roos, B., Valongo, C., Cardoso, M.L., Vilarinho, L., Salomons, G.S., and Jakobs, C., 2004, Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol. Genet. Metab. 82: 214–219.PubMedCrossRefGoogle Scholar
  4. Almeida, L.S., Vilarinho, L., Darmin, P.S., Rosenberg, E.H., Martinez-Munoz, C., Jakobs, C., and Salomons, G.S., 2007, A prevalent pathogenic GAMT mutation (c.59G > C) in Portugal. Mol. Genet. Metab. 91: 1–6.PubMedCrossRefGoogle Scholar
  5. Anselm, I.A., Alkuraya, F.S., Salomons, G.S., Jakobs, C., Fulton, A.B., Mazumdar, M., Rivkin, M., Frye, R., Poussaint, T.Y., and Marsden, D., 2006, X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J. Inherit. Metab. Dis. 29: 214–219.PubMedCrossRefGoogle Scholar
  6. Battini, R., Alessandri, M.G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M.C., and Cioni, G., 2006, Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J. Pediatr. 148: 828–830.PubMedCrossRefGoogle Scholar
  7. Battini, R., Leuzzi, V., Carducci, C., Tosetti, M., Bianchi, M.C., Item, C.B., Stöckler-Ipsiroglu, S., and Cioni, G., 2002, Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol. Genet. Metab. 77: 326–331.PubMedCrossRefGoogle Scholar
  8. Bianchi, M.C., Tosetti, M., Fornai, F., Alessandri’, M.G., Cipriani, P., De, V.G., and Canapicchi, R., 2000, Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann. Neurol. 47: 511–513.PubMedCrossRefGoogle Scholar
  9. Braissant, O., Henry, H., Loup, M., Eilers, B., and Bachmann, C., 2001, Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res. Mol. Brain Res. 86: 193–201.PubMedCrossRefGoogle Scholar
  10. Braissant, O., Henry, H., Villard, A.M., Zurich, M.G., Loup, M., Eilers, B., Parlascino, G., Matter, E., Boulat, O., Honegger, P., and Bachmann, C., 2002, Ammonium-induced impairment of axonal growth is prevented through glial creatine. J. Neurosci. 22: 9810–9820.PubMedGoogle Scholar
  11. Braissant, O., Henry, H., Villard, A.M., Speer, O., Wallimann, T., and Bachmann, C., 2005, Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev. Biol. 5: 9.PubMedCrossRefGoogle Scholar
  12. Braissant, O., Bachmann, C., and Henry, H., 2007, Expression and function of AGAT, GAMT and CT1 in the mammalian brain. Subcell. Biochem. 46: 67–81.PubMedGoogle Scholar
  13. Brewer, G.J., and Wallimann, T.W., 2000, Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J. Neurochem. 74: 1968–1978.PubMedCrossRefGoogle Scholar
  14. Cecil, K.M., Salomons, G.S., Ball, W.S., Jr., Wong, B., Chuck, G., Verhoeven, N.M., Jakobs, C., and Degrauw, T.J., 2001, Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann. Neurol. 49: 401–404.PubMedCrossRefGoogle Scholar
  15. Christie, D.L., 2007, Functional insights into the creatine transporter. Subcell. Biochem. 46: 99–118.CrossRefPubMedGoogle Scholar
  16. Clark, A.J., Rosenberg, E.H., Almeida, L.S., Wood, T.C., Jakobs, C., Stevenson, R.E., Schwartz, C.E., and Salomons, G.S., 2006, X-linked creatine transporter (SLC6A8) mutations in about 1{%} of males with mental retardation of unknown etiology. Hum. Genet. 119: 604–610.PubMedCrossRefGoogle Scholar
  17. De Deyn, P.P., D’Hooge, R., Van Bogaert, P.P., and Marescau, B., 2001, Endogenous guanidino compounds as uremic neurotoxins. Kidney Int. Suppl. 78: S77–S83.PubMedCrossRefGoogle Scholar
  18. De Vries, M., Morava, E., Rodenburg, R., Kluijtmans, L., Verhoeven, N.M., Salomons, G.S., Jakobs, C., and Smeitink, J., 2005, Mitochondrial dysfunction in creatine biosynthesis disorder. J. Inherit. Metab. Dis. 28: 227.Google Scholar
  19. DeGrauw, T.J., Cecil, K.M., Byars, A.W., Salomons, G.S., Ball, W.S., and Jakobs, C., 2003, The clinical syndrome of creatine transporter deficiency. Mol. Cell. Biochem. 244: 45–48.PubMedCrossRefGoogle Scholar
  20. DeGrauw, T.J., Salomons, G.S., Cecil, K.M., Chuck, G., Newmeyer, A., Schapiro, M.B., and Jakobs, C., 2002, Congenital creatine transporter deficiency. Neuropediatrics 33: 232–238.PubMedCrossRefGoogle Scholar
  21. Dolder, M., Walzel, B., Speer, O., Schlattner, U., and Wallimann, T., 2003, Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J. Biol. Chem. 278: 17760–17766.PubMedCrossRefGoogle Scholar
  22. Dringen, R., Verleysdonk, S., Hamprecht, B., Willker, W., Leibfritz, D., and Brand, A., 1998, Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J. Neurochem. 70: 835–840.PubMedCrossRefGoogle Scholar
  23. Item, C.B., Stöckler-Ipsiroglu, S., Stromberger, C., Muhl, A., Alessandri, M.G., Bianchi, M.C., Tosetti, M., Fornai, F., and Cioni, G., 2001, Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am. J. Hum. Genet. 69: 1127–1133.PubMedCrossRefGoogle Scholar
  24. Jinnai, D., Sawai, A., and Mori, A., 1966, Gamma-guanidinobutyric acid as a convulsive substance. Nature 212: 617.PubMedCrossRefGoogle Scholar
  25. Juravleva, E., Barbakadze, T., Mikeladze, D., and Kekelidze, T., 2005, Creatine enhances survival of glutamate-treated neuronal/glial cells, modulates Ras/NF-$\UPkappa $B signaling, and increases the generation of reactive oxygen species. J. Neurosci. Res. 79: 224–230.PubMedCrossRefGoogle Scholar
  26. Kleefstra, T., Rosenberg, E.H., Salomons, G.S., Stroink, H., van Bokhoven, H., Hamel, B.C., and de Vries, B.B., 2005, Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin. Genet. 68: 379–381.PubMedCrossRefGoogle Scholar
  27. Klivenyi, P., Ferrante, R.J., Matthews, R.T., Bogdanov, M.B., Klein, A.M., Andreassen, O.A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., and Beal, M.F., 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5: 347–350.PubMedCrossRefGoogle Scholar
  28. Koga, Y., Takahashi, H., Oikawa, D., Tachibana, T., Denbow, D.M., and Furuse, M., 2005, Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks. Neuroscience 132: 65–71.PubMedCrossRefGoogle Scholar
  29. Limberger, N., Spath, L., and Starke, K., 1986, Release of previously incorporated \UPgamma -[3H]aminobutyric acid in rabbit caudate nucleus slices. J. Neurochem. 46: 1102–1108.PubMedCrossRefGoogle Scholar
  30. Lion-Francois, L., Cheillan, D., Pitelet, G., Acquaviva-Bourdain, C., Bussy, G., Cotton, F., Guibaud, L., Gerard, D., Rivier, C., Vianey-Saban, C., Jakobs, C., Salomons, G.S., and des Portes, V., 2006, High frequency of creatine deficiency syndromes in patients with unexplained mental retardation. Neurology 67: 1713–1714.PubMedCrossRefGoogle Scholar
  31. Loike, J.D., Zalutsky, D.L., Kaback, E., Miranda, A.F., and Silverstein, S.C., 1988, Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc. Natl. Acad. Sci. USA\break 85: 807–811.CrossRefGoogle Scholar
  32. Mancini, G.M., Catsman-Berrevoets, C.E., de Coo, I.F., Aarsen, F.K., Kamphoven, J.H., Huijmans, J.G., Duran, M., van der Knaap, M.S., Jakobs, C., and Salomons, G.S., 2005, Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families. Am. J. Med. Genet. A 132: 288–295.PubMedGoogle Scholar
  33. Matthews, R.T., Ferrante, R.J., Klivenyi, P., Yang, L., Klein, A.M., Mueller, G., Kaddurah-Daouk, R., and Beal, M.F., 1999, Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp. Neurol. 157: 142–149.PubMedCrossRefGoogle Scholar
  34. Matthews, R.T., Yang, L., Jenkins, B.G., Ferrante, R.J., Rosen, B.R., Kaddurah-Daouk, R., and Beal, M.F., 1998, Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease. J. Neurosci. 18: 156–163.PubMedGoogle Scholar
  35. Mercimek-Mahmutoglu, S., Muehl, A., Salomons, G.S., Waldhoer, T., Neophytou, B., Jakobs, C., and Stoeckler-Ipsiroglu, S., 2007, Simultaneous determination of urinary creatine and creatinine by electrospray tandem mass spectrometry for screening of X-linked creatine transporter (SLC6A8) deficiency. Submitted for publication.Google Scholar
  36. Mercimek-Mahmutoglu, S., Stoeckler-Ipsiroglu, S., Adami, A., Appleton, R., Araujo, H.C., Duran, M., Ensenauer, R., Fernandez-Alvarez, E., Garcia, P., Grolik, C., Item, C.B., Leuzzi, V., Marquardt, I., Muhl, A., Saelke-Kellermann, R.A., Salomons, G.S., Schulze, A., Surtees, R., van der Knaap, M.S., Vasconcelos, R., Verhoeven, N.M., Vilarinho, L., Wilichowski, E., and Jakobs, C., 2006, GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 67: 480–484.PubMedCrossRefGoogle Scholar
  37. Neu, A., Neuhoff, H., Trube, G., Fehr, S., Ullrich, K., Roeper, J., and Isbrandt, D., 2002, Activation of GABA$A$ receptors by guanidinoacetate: a novel pathophysiological mechanism. Neurobiol. Dis. 11: 298–307.PubMedCrossRefGoogle Scholar
  38. Newmeyer, A., Cecil, K.M., Schapiro, M., Clark, J.F., and Degrauw, T.J., 2005, Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging. J. Dev. Behav. Pediatr. 26: 276–282.PubMedCrossRefGoogle Scholar
  39. Peral, M.J., Garcia-Delgado, M., Calonge, M.L., Duran, J.M., De La Horra, M.C., Wallimann, T., Speer, O., and Ilundain, A., 2002, Human, rat and chicken small intestinal Na+-Cl--creatine transporter: functional, molecular characterization and localization. J. Physiol. 545: 133–144.PubMedCrossRefGoogle Scholar
  40. Poo-Arguelles, P., Arias, A., Vilaseca, M.A., Ribes, A., Artuch, R., Sans-Fito, A., Moreno, A., Jakobs, C., and Salomons, G., 2006, X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism. J. Inherit. Metab. Dis. 29: 220–223.PubMedCrossRefGoogle Scholar
  41. Pyne-Geithman, G.J., Degrauw, T.J., Cecil, K.M., Chuck, G., Lyons, M.A., Ishida, Y., and Clark, J.F., 2004, Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: a case study. Mol. Cell. Biochem. 262: 35–39.PubMedCrossRefGoogle Scholar
  42. Renema, W.K., Schmidt, A., van Asten, J.J., Oerlemans, F., Ullrich, K., Wieringa, B., Isbrandt, D., and Heerschap, A., 2003, MR spectroscopy of muscle and brain in guanidinoacetate methyltransferase (GAMT)-deficient mice: validation of an animal model to study creatine deficiency. Magn. Reson. Med. 50: 936–943.PubMedCrossRefGoogle Scholar
  43. Rosenberg, E.H., Martínez Muñoz, C., Betsalel, O.T., van Dooren, S.J., Fernandez, M., Jakobs, C., deGrauw, T.J., Kleefstra, T., Schwartz, C.E., and Salomons, G.S., 2007, Functional characterization of missense variants in creatine transporter/SLC6A8: improved diagnostic application. Hum. Mutat., in press.Google Scholar
  44. Rosenberg, E.H., Almeida, L.S., Kleefstra, T., deGrauw, R.S., Yntema, H.G., Bahi, N., Moraine, C., Ropers, H.H., Fryns, J.P., deGrauw, T.J., Jakobs, C., and Salomons, G.S., 2004, High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am. J. Hum. Genet. 75: 97–105.PubMedCrossRefGoogle Scholar
  45. Salomons, G.S., van Dooren, S.J., Verhoeven, N.M., Cecil, K.M., Ball, W.S., Degrauw, T.J., and Jakobs, C., 2001, X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am. J. Hum. Genet. 68: 1497–1500.PubMedCrossRefGoogle Scholar
  46. Schmidt, A., Marescau, B., Boehm, E.A., Renema, W.K., Peco, R., Das, A., Steinfeld, R., Chan, S., Wallis, J., Davidoff, M., Ullrich, K., Waldschutz, R., Heerschap, A., De Deyn, P.P., Neubauer, S., and Isbrandt, D., 2004, Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum. Mol. Genet. 13: 905–921.PubMedCrossRefGoogle Scholar
  47. Schoffelmeer, A.N., Wemer, J., Mulder, A.H., 1981, Comparison between electrically evoked and potassium-induced 3H-noradrenaline release from rat neocortex slices: role of calcium ions and transmitter pools. Neurochem. Int. 3: 129–136.CrossRefPubMedGoogle Scholar
  48. Schulze, A., Mayatepek, E., Bachert, P., Marescau, B., De Deyn, P.P., and Rating, D., 1998, Therapeutic trial of arginine restriction in creatine deficiency syndrome. Eur. J. Pediatr. 157: 606–607.PubMedCrossRefGoogle Scholar
  49. Schulze, A., Bachert, P., Schlemmer, H., Harting, I., Polster, T., Salomons, G.S., Verhoeven, N.M., Jakobs, C., Fowler, B., Hoffmann, G.F., and Mayatepek, E., 2003, Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann. Neurol. 53: 248–251.PubMedCrossRefGoogle Scholar
  50. Schulze, A., Hoffmann, G.F., Bachert, P., Kirsch, S., Salomons, G.S., Verhoeven, N.M., and Mayatepek, E., 2006, Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology 67: 719–721.PubMedCrossRefGoogle Scholar
  51. Schulze, A., and Battini, R., 2007, Pre-symptomatic treatment of creatine biosynthesis defects. Subcell. Biochem. 46: 167–181.PubMedGoogle Scholar
  52. Speer, O., Neukomm, L.J., Murphy, R.M., Zanolla, E., Schlattner, U., Henry, H., Snow, R.J., and Wallimann, T., 2004, Creatine transporters: a reappraisal. Mol. Cell. Biochem. 256–257: 407–424.PubMedCrossRefGoogle Scholar
  53. Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hanicke, W., and Frahm, J., 1994, Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr. Res. 36: 409–413.PubMedGoogle Scholar
  54. Stöckler, S., Hanefeld, F., and Frahm, J., 1996a, Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789–790.CrossRefGoogle Scholar
  55. Stöckler, S., Isbrandt, D., Hanefeld, F., Schmidt, B., and von Figura, K., 1996b, Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am. J. Hum. Genet. 58: 914–922.Google Scholar
  56. Stöckler, S., Marescau, B., De Deyn, P.P., Trijbels, J.M., and Hanefeld, F., 1997, Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. Metabolism 46: 1189–1193.PubMedCrossRefGoogle Scholar
  57. Stöckler-Ipsiroglu, S., and Salomons, G.S., 2006, Creatine deficiency syndromes. In: Fernandes, J., Saudubray, J.-M., van den Berghe, G., and Walter, J.H., eds., Inborn Metabolic Diseases, Diagnosis and Treatment, Springer, Heidelberg, Germany, pp. 211–217.CrossRefGoogle Scholar
  58. Tachikawa, M., Fukaya, M., Terasaki, T., Ohtsuki, S., and Watanabe, M., 2004, Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur. J. Neurosci. 20: 144–160.PubMedCrossRefGoogle Scholar
  59. Tachikawa, M., Hosoya, K.-i., Ohtsuki, S., and Terasaki, T., 2007, A novel relationship between creatine transport at the blood-brain and blood-retinal barriers, creatine biosynthesis, and its use for brain and retinal energy homeostasis. Subcell. Biochem. 46: 83–98.PubMedGoogle Scholar
  60. Tarnopolsky, M.A., Bourgeois, J.M., Snow, R., Keys, S., Roy, B.D., Kwiecien, J.M., and Turnbull, J., 2003, Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: R762–R769.PubMedGoogle Scholar
  61. Torremans, A., Marescau, B., Possemiers, I., Van Dam, D., D’Hooge, R., Isbrandt, D., and De Deyn, P.P., 2005, Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency. J. Neurol. Sci. 231: 49–55.PubMedCrossRefGoogle Scholar
  62. Volpe, J.J., 2001, Neurology of the Newborn, Saunders, Philadelphia.Google Scholar
  63. Walker, J.B., 1979, Creatine: biosynthesis, regulation, and function. Adv. Enzymol. Relat. Areas Mol. Biol. 50: 177–242.PubMedCrossRefGoogle Scholar
  64. Wang, Y.E., Esbensen, P., and Bentley, D., 1998, Arginine kinase expression and localization in growth cone migration. J. Neurosci. 18: 987–998.PubMedGoogle Scholar
  65. Wyss, M., and Kaddurah-Daouk, R., 2000, Creatine and creatinine metabolism. Physiol. Rev. 80: 1107–1213.PubMedGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Sylvia Stockler
    • 1
  • Peter W. Schutz
    • 2
  • Gajja S. Salomons
    • 3
  1. 1.Department of Pediatrics, Division of Biochemical Diseases, British Columbia Children’s HospitalUniversity of British ColumbiaVancouverCanada
  2. 2.Departments of Pediatrics, Pathology and Laboratory Medicine, Division of Biochemical DiseasesUniversity of British Columbia, British Columbia Children’s HospitalVancouverCanada
  3. 3.Department of Clinical Chemistry, Metabolic UnitVU University Medical CenterAmsterdamThe Netherlands

Personalised recommendations